Nidek and Orbis International Partner to Scale Up Artificial Intelligence Eye Screenings in Vietnam
Nidek announced a donation to Orbis International to support Orbis’s artificial intelligence-based screening services in Vietnam. The donation of six specialized fundus cameras, which take images of the retina, will support the scale up of Orbis’ AI-based diabetic retinopathy screening program in Vietnam. These cameras are expected to support the screening of 72,000 patients with diabetes over the next 3 years.
The addition of the Nidek cameras to Orbis’s program will expand its presence to six high-volume screening health facilities in three provinces across Vietnam—including Giao Thuy District Health Center and Nam Dinh General Hospital in Nam Dinh province; Nghe An Endocrinology Hospital and Tay Bac Regional Hospital in Nghe An province; and Can Tho General Hospital and Can Tho Heart Hospital in Can Tho city—improving capacity to detect and promptly treat diabetic retinopathy, a potentially blinding disease that every person with diabetes is at risk of developing.
Images from Nidek's superior desktop fundus cameras will be uploaded to and graded by Cybersight AI, Orbis’s state-of-the-art technology, determining within seconds if diabetic retinopathy is detected. This allows patients the opportunity to be referred immediately for treatment, without first waiting days or even weeks for screening results that rely on human grading of the images.
“According to the Vietnam National Endocrinology Hospital, in the past 20 years, the prevalence of diabetes in the country has increased from 2.7% of the population to 7.3% of the population, and this trend continues to grow,” Ngoc Pham, Country Director, Orbis Vietnam, said in a company news release. “There are not enough trained medical professionals to meet the demand for eye screening for people living with diabetes. Cybersight AI and high-quality cameras will help ease the burden on medical facilities already at capacity by detecting diabetic retinopathy.”
“We are excited and confident that our partnership with Orbis and technological collaboration with their Cybersight AI will certainly improve the diabetic retinopathy screening situation in Vietnam,” said Motoki Ozawa, President and CEO of Nidek. “Our purpose is to provide the joy of vision and health care through our technology and deliver unwavering commitment to people all over the world. We are committed to deliver joy of vision to people in Vietnam by supporting early detection and immediate referrals.”